sFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis
Abstract Background About 90% of cancer-related deaths are due to metastasis of cancer cells, and angiogenesis is a critical step in this process. sFLT01 is a novel fusion protein and a dual-targeting agent that neutralizes both VEGF and PlGF proangiogenic activities. GRP78 dual effect in tumor grow...
Main Authors: | Sepideh Taghizadeh, Zahra-Soheila Soheili, Mehdi Sadeghi, Shahram Samiei, Ehsan Ranaei Pirmardan, Ali Kashanian, Fahimeh Zakeri, Hamid Latifi-Navid, Hoda Shams Najafabadi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Molecular and Cell Biology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12860-021-00367-5 |
Similar Items
-
sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01) -
sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2023-06-01) -
sFlt-1 in Chronic Kidney Disease: Friend or Foe?
by: Masaru Matsui, et al.
Published: (2022-11-01) -
Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01) -
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)